Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ 0Q&(j7`^@
eN,9N]K
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© (vZ-0Ep}
!Z:XSF[T
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© v
f{{z%3T
77O$^fG2
1.Co-stimulators (or co-stimulating molecules) 7[;!e nO
b~,e(D9DG
2.NK-kB <z,)4z++
#\lvzMjCC
3.Immunoglobulin superfamily z eT`kZ
F&czD;F
4.antigen-presenting cell (APC) p lnH
&/WM:]^?0)
5.death domain -[-oz0`Sl{
H
u;"TG
6.CCR and CXCR xjo`u:BH
K/
On|C
7.Lectin (or mitogen) )C8^'*!
(46'#E z[F
8.Clusters of differentiation, CD) ,]2?S5R
?`U_|Yo
9.B7 family 6AAvsu:
3s!6rT_=)d
10.Cytotoxic T lymphocyte, CTL) v zg^tJ
|"SZpx
11.IL-15 and IL-15 receptor (IL-15R) )sm
9%|.&
NlEyT9
12.MHC restriction
AfTm#-R
(WT\HR
13.Affinity-chromatography m|
,Tk:xH
3<r7"/5
14.Cyctosprin A, CsA $k\bP9
k2D*`\
D
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) uBbQJvL
Z5q%L!4G
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© uQO5GDuK>
r*`e%`HU
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 oWY3dc
Qf=^CQ=lV
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
]20:8l'
aH6j,R%
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ }h;Z_XF&
?_gvI
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© ,'(|,f42
%0-oZL
ÃâÒßѧרҵ£º u;t<rEC2
lu{
*]!
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ QfEJU8/5d
IE \RP!
Ïû»¯ÄÚ¿Æ£º ^
`
yhN
"Y+VNS
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ i
7]o[
2@a'n@-
ѪҺ²¡Ñ§×¨Òµ£º .vKgiIC:
Vl1.]'p_
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿